Table of Content

1 Radiopharmaceuticals Market Overview
1.1 Radiopharmaceuticals Product Scope
1.2 Radiopharmaceuticals Segment by Type
1.2.1 Global Radiopharmaceuticals Sales by Type (2016 & 2021 & 2027)
1.2.2 Diagnostic Radioisotopes
1.2.3 Therapeutic Radioisotopes
1.3 Radiopharmaceuticals Segment by Application
1.3.1 Global Radiopharmaceuticals Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Radiopharmaceuticals Market Estimates and Forecasts (2016-2027)
1.4.1 Global Radiopharmaceuticals Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Radiopharmaceuticals Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Radiopharmaceuticals Price Trends (2016-2027)

2 Radiopharmaceuticals Estimates and Forecasts by Region
2.1 Global Radiopharmaceuticals Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Radiopharmaceuticals Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Radiopharmaceuticals Sales Market Share by Region (2016-2021)
2.2.2 Global Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
2.3 Global Radiopharmaceuticals Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Radiopharmaceuticals Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Radiopharmaceuticals Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Radiopharmaceuticals Estimates and Projections (2016-2027)
2.4.2 Europe Radiopharmaceuticals Estimates and Projections (2016-2027)
2.4.3 China Radiopharmaceuticals Estimates and Projections (2016-2027)
2.4.4 Japan Radiopharmaceuticals Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Radiopharmaceuticals Estimates and Projections (2016-2027)
2.4.6 India Radiopharmaceuticals Estimates and Projections (2016-2027)
3 Global Radiopharmaceuticals Competition Landscape by Players
3.1 Global Top Radiopharmaceuticals Players by Sales (2016-2021)
3.2 Global Top Radiopharmaceuticals Players by Revenue (2016-2021)
3.3 Global Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceuticals as of 2020)
3.4 Global Radiopharmaceuticals Average Price by Company (2016-2021)
3.5 Manufacturers Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Radiopharmaceuticals Market Size by Type
4.1 Global Radiopharmaceuticals Historic Market Review by Type (2016-2021)
4.1.1 Global Radiopharmaceuticals Sales Market Share by Type (2016-2021)
4.1.2 Global Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
4.1.3 Global Radiopharmaceuticals Price by Type (2016-2021)
4.2 Global Radiopharmaceuticals Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Radiopharmaceuticals Sales Forecast by Type (2022-2027)
4.2.2 Global Radiopharmaceuticals Revenue Forecast by Type (2022-2027)
4.2.3 Global Radiopharmaceuticals Price Forecast by Type (2022-2027)
5 Global Radiopharmaceuticals Market Size by Application
5.1 Global Radiopharmaceuticals Historic Market Review by Application (2016-2021)
5.1.1 Global Radiopharmaceuticals Sales Market Share by Application (2016-2021)
5.1.2 Global Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
5.1.3 Global Radiopharmaceuticals Price by Application (2016-2021)
5.2 Global Radiopharmaceuticals Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Radiopharmaceuticals Sales Forecast by Application (2022-2027)
5.2.2 Global Radiopharmaceuticals Revenue Forecast by Application (2022-2027)
5.2.3 Global Radiopharmaceuticals Price Forecast by Application (2022-2027)

6 North America Radiopharmaceuticals Market Facts & Figures
6.1 North America Radiopharmaceuticals Sales by Company
6.1.1 North America Radiopharmaceuticals Sales by Company (2016-2021)
6.1.2 North America Radiopharmaceuticals Revenue by Company (2016-2021)
6.2 North America Radiopharmaceuticals Sales Breakdown by Type
6.2.1 North America Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
6.2.2 North America Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
6.3 North America Radiopharmaceuticals Sales Breakdown by Application
6.3.1 North America Radiopharmaceuticals Sales Breakdown by Application (2016-2021)
6.3.2 North America Radiopharmaceuticals Sales Breakdown by Application (2022-2027)

7 Europe Radiopharmaceuticals Market Facts & Figures
7.1 Europe Radiopharmaceuticals Sales by Company
7.1.1 Europe Radiopharmaceuticals Sales by Company (2016-2021)
7.1.2 Europe Radiopharmaceuticals Revenue by Company (2016-2021)
7.2 Europe Radiopharmaceuticals Sales Breakdown by Type
7.2.1 Europe Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
7.2.2 Europe Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
7.3 Europe Radiopharmaceuticals Sales Breakdown by Application
7.3.1 Europe 146 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 146 Sales Breakdown by Application (2022-2027)

8 China Radiopharmaceuticals Market Facts & Figures
8.1 China Radiopharmaceuticals Sales by Company
8.1.1 China Radiopharmaceuticals Sales by Company (2016-2021)
8.1.2 China Radiopharmaceuticals Revenue by Company (2016-2021)
8.2 China Radiopharmaceuticals Sales Breakdown by Type
8.2.1 China Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
8.2.2 China Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
8.3 China Radiopharmaceuticals Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)

9 Japan Radiopharmaceuticals Market Facts & Figures
9.1 Japan Radiopharmaceuticals Sales by Company
9.1.1 Japan Radiopharmaceuticals Sales by Company (2016-2021)
9.1.2 Japan Radiopharmaceuticals Revenue by Company (2016-2021)
9.2 Japan Radiopharmaceuticals Sales Breakdown by Type
9.2.1 Japan Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
9.2.2 Japan Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
9.3 Japan Radiopharmaceuticals Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Radiopharmaceuticals Market Facts & Figures
10.1 Southeast Asia Radiopharmaceuticals Sales by Company
10.1.1 Southeast Asia Radiopharmaceuticals Sales by Company (2016-2021)
10.1.2 Southeast Asia Radiopharmaceuticals Revenue by Company (2016-2021)
10.2 Southeast Asia Radiopharmaceuticals Sales Breakdown by Type
10.2.1 Southeast Asia Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Radiopharmaceuticals Sales Breakdown by Application
10.3.1 Southeast Asia K Dose Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Dose Sales Breakdown by Application (2022-2027)

11 India Radiopharmaceuticals Market Facts & Figures
11.1 India Radiopharmaceuticals Sales by Company
11.1.1 India Radiopharmaceuticals Sales by Company (2016-2021)
11.1.2 India Radiopharmaceuticals Revenue by Company (2016-2021)
11.2 India Radiopharmaceuticals Sales Breakdown by Type
11.2.1 India Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
11.2.2 India Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
11.3 India Radiopharmaceuticals Sales Breakdown by Application
11.3.1 India Radiopharmaceuticals Sales Breakdown by Application (2016-2021)
11.3.2 India Radiopharmaceuticals Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Radiopharmaceuticals Business
12.1 Bracco Imaging
12.1.1 Bracco Imaging Corporation Information
12.1.2 Bracco Imaging Business Overview
12.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bracco Imaging Radiopharmaceuticals Products Offered
12.1.5 Bracco Imaging Recent Development
12.2 Bayer
12.2.1 Bayer Corporation Information
12.2.2 Bayer Business Overview
12.2.3 Bayer Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bayer Radiopharmaceuticals Products Offered
12.2.5 Bayer Recent Development
12.3 Mallinckrodt
12.3.1 Mallinckrodt Corporation Information
12.3.2 Mallinckrodt Business Overview
12.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mallinckrodt Radiopharmaceuticals Products Offered
12.3.5 Mallinckrodt Recent Development
12.4 Nordion
12.4.1 Nordion Corporation Information
12.4.2 Nordion Business Overview
12.4.3 Nordion Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Nordion Radiopharmaceuticals Products Offered
12.4.5 Nordion Recent Development
12.5 Triad Isotopes
12.5.1 Triad Isotopes Corporation Information
12.5.2 Triad Isotopes Business Overview
12.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Triad Isotopes Radiopharmaceuticals Products Offered
12.5.5 Triad Isotopes Recent Development
12.6 Lantheus
12.6.1 Lantheus Corporation Information
12.6.2 Lantheus Business Overview
12.6.3 Lantheus Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Lantheus Radiopharmaceuticals Products Offered
12.6.5 Lantheus Recent Development
12.7 IBA Group
12.7.1 IBA Group Corporation Information
12.7.2 IBA Group Business Overview
12.7.3 IBA Group Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.7.4 IBA Group Radiopharmaceuticals Products Offered
12.7.5 IBA Group Recent Development
12.8 GE Healthcare
12.8.1 GE Healthcare Corporation Information
12.8.2 GE Healthcare Business Overview
12.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.8.4 GE Healthcare Radiopharmaceuticals Products Offered
12.8.5 GE Healthcare Recent Development
12.9 China Isotope & Radiation
12.9.1 China Isotope & Radiation Corporation Information
12.9.2 China Isotope & Radiation Business Overview
12.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.9.4 China Isotope & Radiation Radiopharmaceuticals Products Offered
12.9.5 China Isotope & Radiation Recent Development
12.10 Jubilant Pharma
12.10.1 Jubilant Pharma Corporation Information
12.10.2 Jubilant Pharma Business Overview
12.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Jubilant Pharma Radiopharmaceuticals Products Offered
12.10.5 Jubilant Pharma Recent Development
12.11 Eli Lilly
12.11.1 Eli Lilly Corporation Information
12.11.2 Eli Lilly Business Overview
12.11.3 Eli Lilly Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Eli Lilly Radiopharmaceuticals Products Offered
12.11.5 Eli Lilly Recent Development
12.12 Advanced Accelerator Applications
12.12.1 Advanced Accelerator Applications Corporation Information
12.12.2 Advanced Accelerator Applications Business Overview
12.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Advanced Accelerator Applications Radiopharmaceuticals Products Offered
12.12.5 Advanced Accelerator Applications Recent Development
12.13 SIEMENS
12.13.1 SIEMENS Corporation Information
12.13.2 SIEMENS Business Overview
12.13.3 SIEMENS Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.13.4 SIEMENS Radiopharmaceuticals Products Offered
12.13.5 SIEMENS Recent Development
12.14 Dongcheng
12.14.1 Dongcheng Corporation Information
12.14.2 Dongcheng Business Overview
12.14.3 Dongcheng Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Dongcheng Radiopharmaceuticals Products Offered
12.14.5 Dongcheng Recent Development
12.15 Navidea
12.15.1 Navidea Corporation Information
12.15.2 Navidea Business Overview
12.15.3 Navidea Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Navidea Radiopharmaceuticals Products Offered
12.15.5 Navidea Recent Development

13 Radiopharmaceuticals Manufacturing Cost Analysis
13.1 Radiopharmaceuticals Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Radiopharmaceuticals
13.4 Radiopharmaceuticals Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Radiopharmaceuticals Distributors List
14.3 Radiopharmaceuticals Customers

15 Market Dynamics
15.1 Radiopharmaceuticals Market Trends
15.2 Radiopharmaceuticals Drivers
15.3 Radiopharmaceuticals Market Challenges
15.4 Radiopharmaceuticals Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Radiopharmaceuticals Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Radiopharmaceuticals Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Radiopharmaceuticals Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Radiopharmaceuticals Sales (K Dose) by Region (2016-2021)
Table 5. Global Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 6. Global Radiopharmaceuticals Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Radiopharmaceuticals Revenue Share by Region (2016-2021)
Table 8. Global Radiopharmaceuticals Sales (K Dose) Forecast by Region (2022-2027)
Table 9. Global Radiopharmaceuticals Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Radiopharmaceuticals Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Radiopharmaceuticals Revenue Share Forecast by Region (2022-2027)
Table 12. Global Radiopharmaceuticals Sales (K Dose) of Key Companies (2016-2021)
Table 13. Global Radiopharmaceuticals Sales Share by Company (2016-2021)
Table 14. Global Radiopharmaceuticals Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Radiopharmaceuticals Revenue Share by Company (2016-2021)
Table 16. Global Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceuticals as of 2020)
Table 17. Global Radiopharmaceuticals Average Price (USD/Dose) of Key Company (2016-2021)
Table 18. Manufacturers Radiopharmaceuticals Manufacturing Sites and Area Served
Table 19. Manufacturers Radiopharmaceuticals Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Radiopharmaceuticals Sales (K Dose) by Type (2016-2021)
Table 22. Global Radiopharmaceuticals Sales Share by Type (2016-2021)
Table 23. Global Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Radiopharmaceuticals Price (USD/Dose) by Type (2016-2021)
Table 25. Global Radiopharmaceuticals Sales Share by Type (2022-2027)
Table 26. Global Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Radiopharmaceuticals Revenue Share by Type (2022-2027)
Table 28. Global Radiopharmaceuticals Price (USD/Dose) by Type (2022-2027)
Table 29. Global Radiopharmaceuticals Sales (K Dose) by Application (2016-2021)
Table 30. Global Radiopharmaceuticals Sales Share by Application (2016-2021)
Table 31. Global Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Radiopharmaceuticals Price (USD/Dose) by Application (2016-2021)
Table 33. Global Radiopharmaceuticals Sales (K Dose) by Application (2022-2027)
Table 34. Global Radiopharmaceuticals Sales Share by Application (2022-2027)
Table 35. Global Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Radiopharmaceuticals Revenue Share by Application (2022-2027)
Table 37. Global Radiopharmaceuticals Price (USD/Dose) by Application (2022-2027)
Table 38. North America Radiopharmaceuticals Sales (K Dose) by Company (2016-2021)
Table 39. North America Radiopharmaceuticals Sales Market Share by Company (2016-2021)
Table 40. North America Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Radiopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 42. North America Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 43. North America Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 44. North America Radiopharmaceuticals Sales by Type (2022-2027) & (K Dose)
Table 45. North America Radiopharmaceuticals Sales Market Share by Type (2022-2027)
Table 46. North America Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 47. North America Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 48. North America Radiopharmaceuticals Sales by Application (2022-2027) & (K Dose)
Table 49. North America Radiopharmaceuticals Sales Market Share by Application (2022-2027)
Table 50. Europe Radiopharmaceuticals Sales (K Dose) by Company (2016-2021)
Table 51. Europe Radiopharmaceuticals Sales Market Share by Company (2016-2021)
Table 52. Europe Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Radiopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 54. Europe Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 55. Europe Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 56. Europe Radiopharmaceuticals Sales by Type (2022-2027) & (K Dose)
Table 57. Europe Radiopharmaceuticals Sales Market Share by Type (2022-2027)
Table 58. Europe Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 59. Europe Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 60. Europe Radiopharmaceuticals Sales by Application (2022-2027) & (K Dose)
Table 61. Europe Radiopharmaceuticals Sales Market Share by Application (2022-2027)
Table 62. China Radiopharmaceuticals Sales (K Dose) by Company (2016-2021)
Table 63. China Radiopharmaceuticals Sales Market Share by Company (2016-2021)
Table 64. China Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Radiopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 66. China Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 67. China Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 68. China Radiopharmaceuticals Sales by Type (2022-2027) & (K Dose)
Table 69. China Radiopharmaceuticals Sales Market Share by Type (2022-2027)
Table 70. China Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 71. China Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 72. China Radiopharmaceuticals Sales by Application (2022-2027) & (K Dose)
Table 73. China Radiopharmaceuticals Sales Market Share by Application (2022-2027)
Table 74. Japan Radiopharmaceuticals Sales (K Dose) by Company (2016-2021)
Table 75. Japan Radiopharmaceuticals Sales Market Share by Company (2016-2021)
Table 76. Japan Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Radiopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 78. Japan Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 79. Japan Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 80. Japan Radiopharmaceuticals Sales by Type (2022-2027) & (K Dose)
Table 81. Japan Radiopharmaceuticals Sales Market Share by Type (2022-2027)
Table 82. Japan Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 83. Japan Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 84. Japan Radiopharmaceuticals Sales by Application (2022-2027) & (K Dose)
Table 85. Japan Radiopharmaceuticals Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Radiopharmaceuticals Sales (K Dose) by Company (2016-2021)
Table 87. Southeast Asia Radiopharmaceuticals Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Radiopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 91. Southeast Asia Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Radiopharmaceuticals Sales by Type (2022-2027) & (K Dose)
Table 93. Southeast Asia Radiopharmaceuticals Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 95. Southeast Asia Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Radiopharmaceuticals Sales by Application (2022-2027) & (K Dose)
Table 97. Southeast Asia Radiopharmaceuticals Sales Market Share by Application (2022-2027)
Table 98. India Radiopharmaceuticals Sales (K Dose) by Company (2016-2021)
Table 99. India Radiopharmaceuticals Sales Market Share by Company (2016-2021)
Table 100. India Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Radiopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 102. India Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 103. India Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 104. India Radiopharmaceuticals Sales by Type (2022-2027) & (K Dose)
Table 105. India Radiopharmaceuticals Sales Market Share by Type (2022-2027)
Table 106. India Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 107. India Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 108. India Radiopharmaceuticals Sales by Application (2022-2027) & (K Dose)
Table 109. India Radiopharmaceuticals Sales Market Share by Application (2022-2027)
Table 110. Bracco Imaging Corporation Information
Table 111. Bracco Imaging Description and Business Overview
Table 112. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. Bracco Imaging Radiopharmaceuticals Product
Table 114. Bracco Imaging Recent Development
Table 115. Bayer Corporation Information
Table 116. Bayer Description and Business Overview
Table 117. Bayer Radiopharmaceuticals Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. Bayer Radiopharmaceuticals Product
Table 119. Bayer Recent Development
Table 120. Mallinckrodt Corporation Information
Table 121. Mallinckrodt Description and Business Overview
Table 122. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. Mallinckrodt Radiopharmaceuticals Product
Table 124. Mallinckrodt Recent Development
Table 125. Nordion Corporation Information
Table 126. Nordion Description and Business Overview
Table 127. Nordion Radiopharmaceuticals Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. Nordion Radiopharmaceuticals Product
Table 129. Nordion Recent Development
Table 130. Triad Isotopes Corporation Information
Table 131. Triad Isotopes Description and Business Overview
Table 132. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 133. Triad Isotopes Radiopharmaceuticals Product
Table 134. Triad Isotopes Recent Development
Table 135. Lantheus Corporation Information
Table 136. Lantheus Description and Business Overview
Table 137. Lantheus Radiopharmaceuticals Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 138. Lantheus Radiopharmaceuticals Product
Table 139. Lantheus Recent Development
Table 140. IBA Group Corporation Information
Table 141. IBA Group Description and Business Overview
Table 142. IBA Group Radiopharmaceuticals Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 143. IBA Group Radiopharmaceuticals Product
Table 144. IBA Group Recent Development
Table 145. GE Healthcare Corporation Information
Table 146. GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 147. GE Healthcare Description and Business Overview
Table 148. GE Healthcare Radiopharmaceuticals Product
Table 149. GE Healthcare Recent Development
Table 150. China Isotope & Radiation Corporation Information
Table 151. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 152. China Isotope & Radiation Description and Business Overview
Table 153. China Isotope & Radiation Radiopharmaceuticals Product
Table 154. China Isotope & Radiation Recent Development
Table 155. Jubilant Pharma Corporation Information
Table 156. Jubilant Pharma Description and Business Overview
Table 157. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 158. Jubilant Pharma Radiopharmaceuticals Product
Table 159. Jubilant Pharma Recent Development
Table 160. Eli Lilly Corporation Information
Table 161. Eli Lilly Description and Business Overview
Table 162. Eli Lilly Radiopharmaceuticals Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 163. Eli Lilly Radiopharmaceuticals Product
Table 164. Eli Lilly Recent Development
Table 165. Advanced Accelerator Applications Corporation Information
Table 166. Advanced Accelerator Applications Description and Business Overview
Table 167. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 168. Advanced Accelerator Applications Radiopharmaceuticals Product
Table 169. Advanced Accelerator Applications Recent Development
Table 170. SIEMENS Corporation Information
Table 171. SIEMENS Description and Business Overview
Table 172. SIEMENS Radiopharmaceuticals Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 173. SIEMENS Radiopharmaceuticals Product
Table 174. SIEMENS Recent Development
Table 175. Dongcheng Corporation Information
Table 176. Dongcheng Description and Business Overview
Table 177. Dongcheng Radiopharmaceuticals Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 178. Dongcheng Radiopharmaceuticals Product
Table 179. Dongcheng Recent Development
Table 180. Navidea Corporation Information
Table 181. Navidea Description and Business Overview
Table 182. Navidea Radiopharmaceuticals Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 183. Navidea Radiopharmaceuticals Product
Table 184. Navidea Recent Development
Table 185. Production Base and Market Concentration Rate of Raw Material
Table 186. Key Suppliers of Raw Materials
Table 187. Radiopharmaceuticals Distributors List
Table 188. Radiopharmaceuticals Customers List
Table 189. Radiopharmaceuticals Market Trends
Table 190. Radiopharmaceuticals Market Drivers
Table 191. Radiopharmaceuticals Market Challenges
Table 192. Radiopharmaceuticals Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceuticals Product Picture
Figure 2. Global Radiopharmaceuticals Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Radiopharmaceuticals Sales Market Share by Application in 2021 & 2027
Figure 6. Oncology Examples
Figure 7. Cardiology Examples
Figure 8. Other Examples
Figure 9. Global Radiopharmaceuticals Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Radiopharmaceuticals Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Radiopharmaceuticals Sales (K Dose) Growth Rate (2016-2027)
Figure 12. Global Radiopharmaceuticals Price Trends Growth Rate (2016-2027) (USD/Dose)
Figure 13. Global Radiopharmaceuticals Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Radiopharmaceuticals Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Radiopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Radiopharmaceuticals Sales (K Dose) Growth Rate (2016-2027)
Figure 17. Europe Radiopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Radiopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Radiopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Radiopharmaceuticals Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Radiopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Radiopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Radiopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Radiopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Radiopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Radiopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Radiopharmaceuticals Players Market Share by Revenue in Radiopharmaceuticals: 2016 & 2020
Figure 28. Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Radiopharmaceuticals Revenue Share by Type (2016-2021)
Figure 30. Global Radiopharmaceuticals Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Radiopharmaceuticals Revenue Share by Application (2016-2021)
Figure 32. Global Radiopharmaceuticals Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 34. North America Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 35. Europe Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 36. Europe Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 37. China Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 38. China Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 39. Japan Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 40. Japan Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 41. Southeast Asia Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 42. Southeast Asia Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 43. India Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 44. India Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Radiopharmaceuticals
Figure 47. Manufacturing Process Analysis of Radiopharmaceuticals
Figure 48. Radiopharmaceuticals Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed